- Reaction score
Your Wikipedia source is pretty weak compared to his actual credentials and the company he keeps, found here:Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread use of unproven drugs as treatments. Kory testified in front of the U.S. Senate twice regarding COVID-19. During his testimony on December 8, 2020, Kory erroneously claimed that the antiparasitic medication invermectin was a "wonder drug" with "miraculous effectiveness" against COVID-19.
Is this the same paper?
The MATH+ Hospital Treatment Protocol for Covid-19 is a physiologic-based combination treatment regimen created by leaders in critical care medicine.
Here is an example of a Covid 19 Critical Care co-founder he works with, Dr. Marik:
Dr. Marik has special knowledge and training in a diverse set of medical fields, with specific training in Internal Medicine, Critical Care, Neurocritical Care, Pharmacology, Anesthesia, Nutrition, and Tropical Medicine and Hygiene. Dr. Marik is currently a tenured Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School in Norfolk, Virginia. Dr. Marik has written over 500 peer-reviewed journal articles, 80 book chapters and authored four critical care books. He has been cited over 43,000 times in peer-reviewed publications and has an H-index of 77. He has delivered over 350 lectures at international conferences and visiting professorships. He has received numerous teaching awards, including the National Teacher of the Year award by the American College of Physicians in 2017. He is the 2nd most published critical care physician in the world ever, and is a world renowned expert in the management of sepsis – his contributions to the understanding and management of the hemodynamic, fluid, nutritional, and supportive care practices in sepsis have transformed the care of patients throughout the world. He also led the Society of Critical Care Medicine task force on corticosteroids in sepsis. He has already co-authored 10 papers on many therapeutic aspects of COVID-19.